Pierre Ingrand

Pierre Ingrand

Auto-generated profile, based on publicly available information

Pierre Ingrand

CIC 1402, Clinical Investigation center, Bio-statistic and epidemiology, University of Poitiers, 86021 Poitiers, France

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2014 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
GDGautier DEFOSSEZ
Gautier DEFOSSEZ
ARAlexandre Rollet
Alexandre Rollet
ODOlivier Dameron
Olivier Dameron
PIPierre Ingrand
Pierre Ingrand
Ensuring that all cancer patients have access to the appropriate treatment within an appropriate time is a strategic priority in many countries. There is in particular a need to describe and analyse cancer care trajectories and to produce waiting time indicators. We developed an algorithm for extracting temporally represented care trajectories from coded information collected routinely by the general cancer Registry in Poitou-Charentes region, France. The present work aimed to assess the performance of this algorithm on real-life patient data in the setting of non-metastatic breast cancer, using measures of similarity.

16 July 2007 in BMC Cancer
Verified
Journal Article
Open access
PDF file
TNthe REPERES research network
the REPERES research network
GDGautier DEFOSSEZ
Gautier DEFOSSEZ
SMSimone Mathoulin-Pelissier
Simone Mathoulin-Pelissier
IIIsabelle Ingrand
Isabelle Ingrand
IGIsabelle Gasquet
Isabelle Gasquet
VMVirginie Migeot
Virginie Migeot
The care itinerary for cancer involves difficulties that occur in several different areas, whether in the diagnostic procedures, in surgery, or in adjuvant treatment. The aim of this work was to obtain a valid instrument measuring satisfaction among patients with breast cancer and exploring their care itinerary overall.

28 October 2019 in British Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
IIIsabelle Ingrand
Isabelle Ingrand
GDGautier DEFOSSEZ
Gautier DEFOSSEZ
CLClaire Lafay‐Chebassier
Claire Lafay‐Chebassier
FCFrançois Chavant
François Chavant
AFAurélie Ferru
Aurélie Ferru
MPMarie‐Christine Pérault‐Pochat
Marie‐Christine Pérault‐Pochat
Aims: Pharmaco‐epidemiological surveys enable the frequency of serious adverse effects—and also the determining factors of their occurrence and seriousness—to be quantified. Few studies systematically gathering post‐chemotherapy adverse effects data have been conducted. The objective was to assess the incidence of post‐chemotherapy serious adverse effects on the basis of cancer registry data.Methods: The population was composed of new invasive cancer cases, with the exception of haematopoietic tumours and cutaneous carcinomas. These cancers were identified in 2012 among patients living at the time of diagnosis in a region covered by a general cancer registry and by a French regional pharmacovigilance centre, and treated with neo‐adjuvant and/or adjuvant first‐intention chemotherapy, followed or not by radiotherapy. The study was based on a sample of 1000 patients from the registry, followed by the collection of serious adverse effects and the required information to constitute a pharmacovigilance file.Results: Chemotherapy was associated with a particularly high incidence of serious adverse effects, affecting 44.5% (41.4–47.5%) of the patients. The highest incidence rates were observed when patients were exposed to topo‐isomerase II inhibitors such as etoposide and bleomycin (69.2%), vinca‐alkaloids (66.7%), topo‐isomerase I inhibitors (54.5%) and platinum derivatives (52.0%). The clinical context was also linked to incidence, especially in case of metastases (53.3%) and comorbidities (51.3%). Substantial differences were found according to localisation, with a particularly high incidence in bronchial–pulmonary cancers (59.0%).Conclusion: The high overall incidence rate of serious adverse effects should motivate a reinforcement of information about drug toxicities and improve knowledge by drawing on patient reporting.

1 August 2016 in Medicine
Verified
Journal Article
Open access
IIIsabelle Ingrand
Isabelle Ingrand
GDGautier DEFOSSEZ
Gautier DEFOSSEZ
JRJean-Pierre Richer
Jean-Pierre Richer
DTDavid Tougeron
David Tougeron
NPNicolas Palierne
Nicolas Palierne
PIPierre Ingrand
Pierre Ingrand
Colonoscopic screening is recommended for first-degree relatives of patients diagnosed with colorectal cancer (CRC) or colorectal adenomatous polyps (CAP) before the age of 60 years. This has the potential to reduce CRC-related morbidity and mortality, but uptake is currently inadequate. The aim of the study was to compare the effectiveness of standard information versus a nurse-led tailored intervention designed to promote uptake of colonoscopy screening by siblings of CRC or CAP patients. A randomized controlled trial was conducted. Digestive surgeons and gastroenterologists recruited index patients who developed CRC or CAP before the age of 60 years. All index patients received standard screening information for their siblings, in keeping with current guidelines. Centrally computerized randomization of index patients resulted in allocating all their siblings to the same group, intervention or control. The tailored intervention targeted the index patient first, to help them convey information to their siblings. The nurse then provided the siblings with tailored information based on their answers to a self-questionnaire which explored health behaviors, derived from psychosocial models of prevention. Then the siblings were given a personalized information leaflet to hand to their regular physician. The primary endpoint was the rate of documented colonoscopy performed in siblings within 1 year after diagnosis of the index patient. The intent-to-treat analysis included siblings who refused to participate in the study. Statistical analysis was adjusted for intrafamilial correlation. A total of 304 siblings of 125 index patients were included: 160 in the intervention group and 144 in the control group. The rate of colonoscopy uptake among siblings was 56.3% in the intervention group and 35.4% in the control group (P = 0.0027). The respective rates after exclusion of refusals were 69.2% and 37.0% (P < 0.0001). More lesions were detected in the intervention group (1 invasive cancer and 11 advanced adenomas vs 5 advanced adenomas; P = 0.022). This study demonstrates the effectiveness of a nurse-led tailored intervention designed to promote colonoscopy screening uptake by siblings of patients diagnosed with CRC or CAP before age 60 years. Such tailored interventions that also involve physicians should help to reduce CRC-related mortality.

7 August 2019 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
PDF file
EAEVA MARIA Arroyo-Anlló
EVA MARIA Arroyo-Anlló
SDStéphanie Dauphin
Stéphanie Dauphin
MFM. Noelle Fargeau
M. Noelle Fargeau
PIPierre Ingrand
Pierre Ingrand
RGRoger Gil
Roger Gil
Alzheimer’s disease may compromise several musical competences, though no clear data is available in the scientific literature. Furthermore, music is capable of communicating basic emotions, but little is known about the emotional aspect of music in patients with Alzheimer’s disease. We present a systematic investigation of music processing in relation to extra-musical skills, in particular emotional skills in patients with Alzheimer’s disease. We tested 30 patients with mild or moderate Alzheimer’s disease and 30 control subjects. We essentially evaluated (a) musical competences, using the extra-linguistic test, Solfeggio test and the recognition test of musical emotions—elaborated by our research team—and the Seashore test, and (b) emotional capacities using emotional memory and emotional prosody tests—made by our research group. We significantly observed lower total results of every test assessing cognitive, emotional and music competences in Alzheimer’s disease patients than those in control subjects, but the score of musical emotion recognition test did not reach to a significant difference between the subjects groups. Our findings found a global impairment of music competences in Alzheimer patients with cognitive and emotional troubles. Nevertheless, the performances in the recognition test of musical emotions showed a trend towards a performance difference. We can suggest that Alzheimer’s disease currently presents an aphaso-agnoso-apractic-amusia syndrome.

6 July 2010 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MTMyriam Taouqi
Myriam Taouqi
IIIsabelle Ingrand
Isabelle Ingrand
MBMichel Beauchant
Michel Beauchant
VMVirginie Migeot
Virginie Migeot
PIPierre Ingrand
Pierre Ingrand
Background: Targeted colonosocopic screening is recommended for first-degree relatives of colorectal cancer patients diagnosed before the age of 60 and offers the possibility of reducing morbidity and mortality, but participation remains too low. The objective of this study was to determine in a French population the factors that affect siblings' participation in screening, notably those relating to the individuals, their medical care, their family and their social network.Methods: A cross sectional survey was conducted in siblings of index patients having undergone surgery for colorectal cancer between 1999 and 2002 in two French counties. Siblings were contacted during 2007 and 2008 through the index patient. The factors affecting participation in colonoscopic screening were studied by logistic regression taking into account family cluster effect.Results: 172 siblings of 74 index cases were included. The declared rate of undergoing at least one colonoscopy among siblings was 66%; 95%CI 59-73%. Five variables were independently associated with colonoscopic screening: perceiving fewer barriers to screening (OR = 3.2; 95%CI 1.2-8.5), having received the recommendation to undergo screening from a physician (OR = 4.9; 1.7-13.7), perceiving centres practising colonoscopy as more accessible (OR = 3.2, 1.3-7.8), having discussed screening with all siblings (OR = 3.9; 1.6-9.6) and being a member of an association (OR = 2.6; 1.0-6.6).Conclusions: The factors independently associated with participation in CRC screening by an individual at increased risk belonged to each of four dimensions relating to his individual psychosocial characteristics, to his relationship with a physician, within the family and social environment. The relevance of these results to clinical practice may help to improve compliance to recommendations in a global preventive strategy including all stages of the information pathway from the physician to the index patient and his relatives.